HSF1 (Heat-Shock Factor 1)

The master transcriptional activator of the cellular heat-shock response — a trimeric transcription factor that senses proteotoxic stress, translocates to the nucleus, and drives coordinated induction of the hsp70, hsp90, and hsp40 chaperone families. Centrally relevant to aging via its role in loss-of-proteostasis: HSF1 activity declines with organismal age, compromising the cell’s ability to clear misfolded proteins, and HSF1 is required for lifespan extension by reduced insulin/IGF-1 signaling in C. elegans.

Identity

UniProt: Q00613 (HSF1_HUMAN) — Swiss-Prot (manually curated) entry
NCBI Gene: 3297
HGNC symbol: HSF1
Ensembl: ENSG00000185122
Mouse ortholog: Hsf1 (one-to-one; highly conserved)
Mass / length: ~57 kDa; 529 amino acids (canonical human isoform 1) ¹

Domain architecture

HSF1 is organized into four functionally distinct regions ¹:

Domain	Residues (approx.)	Function
DNA-binding domain (DBD)	15–110	Sequence-specific binding to heat-shock elements (HSEs)
Leucine-zipper oligomerization (HR-A/B)	130–221	Coiled-coil; mediates trimerization upon stress activation
Regulatory domain	203–383	Intrinsically disordered; major site of PTMs; integrates stress signals
Transactivation domain (TAD)	410–529	Contacts Mediator/TBP; drives pol II recruitment

A second coiled-coil region (HR-C) near the C-terminus maintains the monomer in an inactive conformation by intramolecular interaction with HR-A/B; stress-induced unfolding of HR-C releases the oligomerization interface ¹.

Function — activation cycle

Under basal (non-stress) conditions, HSF1 is held as a latent monomer primarily in the nucleus — it carries a potent bipartite nuclear localization signal and the majority of HSF1 is nuclear before and after heat stress — through association with the hsp70 / hsp90 chaperone complex ¹. This constitutes a negative feedback loop: chaperones that HSF1 itself induces compete for binding and suppress HSF1 activity when proteostatic load is low.

Upon proteotoxic stress (heat, oxidative damage, proteasome inhibition, misfolded-protein accumulation), titration of hsp70 and hsp90 onto denatured client proteins releases HSF1. The freed HSF1 then:

Trimerizes via HR-A/B coiled-coil contacts.
Undergoes activating PTMs — most notably Ser326 phosphorylation (activating) and suppressive Ser303/Ser307 phosphorylation (fine-tuned by ERK1/2, GSK-3β per Anckar 2011 Table 1).
Accumulates in the nucleus (HSF1 is already predominantly nuclear at basal conditions; heat shock inhibits its cytoplasmic export, increasing nuclear concentration further) ¹.
Binds heat-shock elements (HSEs) — inverted repeats of the sequence nGAAn arranged in at least three adjacent units — in the promoters of chaperone genes ¹.
Drives transcription of hsp70 (HSPA1A/HSPA1B), HSPA6, HSPC (Hsp90), DNAJB1 (Hsp40), HSPB1 (Hsp27), and several hundred additional stress-responsive targets.

Chaperone re-accumulation then re-engages HSF1 and terminates the response.

Aging relevance

HSF1 activity declines with age

HSF1 DNA-binding activity, trimer formation, and transcriptional induction of heat-shock genes all decline measurably in aged tissues compared with young counterparts, both in rodents and in human cell models ¹. The mechanistic basis is not fully resolved but likely involves age-associated increases in constitutive HSF1 phosphorylation (Ser303/Ser307) that bias toward the suppressed state, as well as general transcriptional attenuation. no-mechanism

HSF1 is required for IIS-pathway lifespan extension in C. elegans

In the canonical model for HSF1’s role in longevity: DAF-16 (the FOXO transcription factor activated by reduced insulin/IGF-1 signaling) drives lifespan extension only when HSF1 is present. RNAi knockdown of hsf-1 fully suppresses the long-lived phenotype of daf-2 mutants (reduced IIS), placing HSF1 genetically downstream of or parallel to DAF-16 in the lifespan-extension pathway ².

Specifically, Hsu et al. 2003 showed that hsf-1(RNAi) reduced mean lifespan by ~30–40% in WT worms and completely abolished the lifespan extension of daf-2(e1370) mutants ². (Morley & Morimoto 2004, using adult-stage RNAi initiation, found a smaller ~23% reduction in wild-type mean lifespan — N2;vector 23.2 d vs N2;hsf-1(RNAi) 17.9 d at 20°C — consistent with the difference reflecting developmental vs adult RNAi timing ³.) Morley & Morimoto 2004 further demonstrated that HSF1 overexpression (ubiquitous, let-858 promoter) extends worm lifespan by 22% (16.8 ± 0.5 d vs 13.8 ± 0.5 d control at 25°C, p<0.001) and that HSF1 + DAF-16 act together to maintain protein-folding quality with age ³.

Dimension	Status	Notes
Pathway conserved in humans?	yes	HSF1 trimerization and HSE-binding mechanism identical; human cells reconstitute worm HSF1 function
Phenotype conserved in humans?	partial	HSF1 activity correlates with proteostasis capacity in human aging; no direct lifespan data
Replicated in humans?	no	Worm IIS-HSF1 lifespan extension not directly tested in humans needs-human-replication

HSF1 haploinsufficiency in mice

Hsf1+/- mice display accelerated age-related decline in specific tissues including lens and nervous system, and reduced thermotolerance, consistent with a dosage-sensitive role in maintaining proteostasis under stress. Full Hsf1-/- mice are viable but infertile and highly sensitized to proteotoxic challenge. needs-replication — mouse haploinsufficiency data comes from limited studies; aging phenotype characterization is incomplete.

Activation stimuli

Heat — classical inducer; threshold ~42°C in human cells (HSF1 trimerization occurs within minutes)
Proteotoxic chemicals — proteasome inhibitors (MG-132, bortezomib), heavy metals, arsenite
Oxidative stress — glutathione depletion, H2O2 (partially; synergizes with heat)
heat-exposure — sauna (80–100°C air, ~38–40°C core) transiently activates HSF1 in peripheral blood mononuclear cells; magnitude of induction modest versus in-vitro heat shock dose-response-unclear
exercise — strenuous exercise modestly activates HSF1 in skeletal muscle; effect smaller than thermal stress and context-dependent needs-replication

Therapeutic angles

Direct HSF1 activators

HSF1A — small molecule identified in a yeast screen; binds TRiC/CCT chaperonin, indirectly releasing HSF1 from suppression. Active in cell-culture and invertebrate models; no human data. needs-human-replication unsourced — attribution to Anckar 2011 removed; Anckar 2011 does not describe HSF1A. Original source is Neef et al. 2010 (ACS Chem. Biol.); wiki footnote needs replacement citation.
NXP800 — HSP90 inhibitor / HSF1 modulator; entered Phase 1 in ovarian cancer (as HSF1 pathway suppressor in cancer context — note the paradox below). needs-canonical-id for NXP800 clinical trial NCT identifier.

Indirect activation

Heat exposure / whole-body hyperthermia — the most validated route to HSF1 activation in humans; see heat-exposure. Physiological heat stress (sauna) is well-tolerated and activates the heat-shock response broadly.
Natural products with HSF1-activating activity — celastrol (from Tripterygium wilfordii) and withaferin-A (from ashwagandha) activate HSF1 in cell models at low micromolar concentrations, likely via induction of proteotoxic stress rather than direct HSF1 binding. Human bioavailability and safety at effective doses unclear. dose-response-unclear

Cancer connection — therapeutic paradox

HSF1 is substantially overexpressed and constitutively active in many human cancer types, where it drives a transcriptional program that supports cancer-cell proteostasis, proliferation, and survival in the tumor microenvironment — the concept of “non-oncogene addiction” ⁴. Importantly, this cancer-associated HSF1 program is distinct from the classical heat-shock response: it involves a different set of target genes and operates independently of acute proteotoxic stress ⁴.

This creates a therapeutic paradox for aging: pharmacological activation of HSF1 to support proteostasis in aging tissues could, in principle, accelerate or support oncogenic contexts. Conversely, several cancer programs target HSF1 for inhibition. Any HSF1-activating anti-aging intervention must be evaluated for cancer risk, particularly in older individuals with accumulating somatic mutations. contradictory-evidence

Cross-references

heat-shock-response — the pathway HSF1 orchestrates (R25+ implicit stub)
hsp70 — primary transcriptional target and negative regulator of HSF1
loss-of-proteostasis — the hallmark of aging most directly connected to HSF1 decline
heat-exposure — lifestyle intervention that activates HSF1 (R23c page)
exercise — secondary activator of HSF1 in muscle

Limitations and gaps

HSF1 activity decline with age — mechanism unclear. The age-associated shift in HSF1 PTM landscape has been documented but the upstream drivers (kinase/phosphatase changes, redox shifts) are not well resolved. no-mechanism
Human lifespan data absent. All lifespan-extension data is from C. elegans (and partly yeast/fly). Mouse data covers tissue-level proteostasis decline but no lifespan extension by HSF1 overexpression in mice has been robustly established. needs-human-replication
Druggability tier not assessed. Open Targets Platform entry not checked for HSF1 druggability score. needs-canonical-id
GTEx aging correlation not populated. Age-stratified expression data from GTEx not yet pulled for this page. See sops/finding-tissue-expression.md.
Cancer-aging tradeoff unquantified. The magnitude of cancer risk increase from HSF1 activation at aging-relevant doses is unknown. no-mechanism

Footnotes

doi:10.1146/annurev-biochem-060809-095203 · Anckar J & Sistonen L · Annu Rev Biochem 2011;80:1089–1115 · review · model: mechanistic review of HSF1 regulation; locally available PDF ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷
doi:10.1126/science.1083701 · Hsu AL, Murphy CT, Kenyon C · Science 2003;300:1142–1145 · in-vivo · model: C. elegans daf-2(e1370) + hsf-1(RNAi); n not specified per group; HSF-1 required for DAF-16-mediated lifespan extension; lifespan reduction by hsf-1 RNAi characterized as 30–40% per Anckar 2011 review summary · PDF not available (not_oa); verified via abstract + Anckar 2011 characterization only no-fulltext-access ↩ ↩²
doi:10.1091/mbc.e03-07-0532 · Morley JF, Morimoto RI · Mol Biol Cell 2004;15:657–664 · in-vivo · model: C. elegans; HSF1 overexpression extends lifespan; HSF1 + DAF-16 maintain proteostasis with age ↩ ↩²
doi:10.1016/j.cell.2012.06.031 · Mendillo ML et al. · Cell 2012;150:549–562 · in-vitro / clinical genomics · model: human cancer cell lines + primary tumor expression data; HSF1 drives cancer-specific transcriptional program distinct from classical heat shock ↩ ↩²

🧬 Aging Wiki

Explorer

hsf1